Market Overview

Know Labs Announces UBAND™ Calorie Counter Wristband


Based Upon Invention of Non-Invasive Blood Glucose Measurement

Know Labs, Inc. (OTCQB:KNWN) – a provider of identification,
authentication and diagnostic solutions, published an advertisement in
the Seattle Times newspaper today announcing its UBAND™ real time
wearable calorie counter wrist band. The first 1000 respondents to the
ad can get on the list to obtain the UBAND for $99. The Calorie Counter
UBAND is built upon the Company's recent invention that detects blood
glucose non-invasively. We expect an automatic calorie counter to be in
demand by people who like to keep fit and maintain a healthy lifestyle.

This press release features multimedia. View the full release here:

(Graphic: Business Wire)

(Graphic: Business Wire)

About Know Labs, Inc.

Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose
shares currently trade under the stock symbol "KNWN." The company's
technology directs structured light or radio waves through a substance
or material to capture a unique molecular signature. The Company refers
to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio-RFID
are used to identify, detect or diagnose substance markers or biomarkers
that may be invisible to the human eye. ChromaID and Bio-RFID scanner
modules can be integrated into a variety of wearable, mobile or
bench-top form factors. This patented and patent-pending, award-winning
technology makes it possible to effectively conduct analyses that could
only previously be performed by invasive and/or large and expensive
lab-based tests. UBAND™, ChromaID™ and Bio-RFID™ are trademarks of Know
Labs, Inc. For more information on Know Labs, visit the company's
website at

This release contains statements that constitute forward-looking
statements within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended. These statements appear in a number of places in this
release and include all statements that are not statements of historical
fact regarding the intent, belief or current expectations of Know Labs,
Inc., its directors or its officers with respect to, among other things:
(i) financing plans; (ii) trends affecting its financial condition or
results of operations; (iii) growth strategy and operating strategy. The
words may, would, will, expect, estimate, can, believe, potential and
similar expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any such
forward-looking statements are not guarantees of future performance and
involve risks and uncertainties, many of which are beyond Know Labs,
Inc.'s ability to control, and actual results may differ materially from
those projected in the forward-looking statements as a result of various

View Comments and Join the Discussion!